MAPT and Alzheimer disease: We found previously that acute infusion of oligomeric recombinant human 4R/2N tau into the brains of mice elicited impairments in short‐term spatial memory tasks that are used to model the types of hippocampus‐dependent cognitive impairments exhibited by patients with AD.3